SODIUM HYDROXIDE SOLUTION (25%) AND SODIUM HRDOXIDE SOLUTION (50%) POUNDS

Project: SODIUM HYDROXIDE SOLUTION (25%) AND SODIUM HRDOXIDE SOLUTION (50%) POUNDS Ref. #: 1-24-2-14-5 Type: IFB Status: Open Open Date: Oct 19th 2023, 9:00 AM EDT Intent to Bid Due Date: Nov 16th 2023, 12:00 PM EST Questions Due Date: Nov 2nd 2023, 1:00 PM EDT Close Date: Nov 16th 2023, 12:00 PM EST Days Left: 4 Project Description:The Maryland Environmental Service is soliciting competitive sealed bids from qualified Contractors to provide sodium hydroxide solution (25%) and sodium hydroxide solution (50%) pounds located at the Dundalk marine Terminal ground water treatment plant, 2700 Broening hwy., Bldg. 1400 Baltimore, MD 21222 Important Events:OngoingOpen DateOnline PortalPosting date for the OpportunityOct 19th 2023, 9:00 AM EDTN/AUpcomingBid Opening+13322490605,,369402768#

href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDc0NDhmM2MtZTBhNi00MmVhLTkxMzgtMzFhMDNjYTY4NGNj%40thread.v2/0?context=%7b%22Tid%22%3a%224c44e1cf-7dae-454f-a18f-c18a6a12f9d7%22%2c%22Oid%22%3a%22258e8105-1d06-446c-8f6c-9ed710615f21%22%7d" target="_blank">https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDc0NDhmM2MtZTBhNi00MmVhLTkxMzgtMzFhMDNjYTY4NGNj%40thread.v2/0?context=%7b%22Tid%22%3a%224c44e1cf-7dae-454f-a18f-c18a6a12f9d7%22%2c%22Oid%22%3a%22258e8105-1d06-446c-8f6c-9ed710615f21%22%7d Or call in (audio only) +1 332-249-0605,,369402768# United States, New York City Phone Conference ID: 369 402 768#Nov 16th 2023, 12:00 PM EST - Nov 16th 2023, 12:30 PM ESTNoUpcomingClose DateOnline PortalDeadline for SubmissionsNov 16th 2023, 12:00 PM ESTN/AUpcomingIntent to Bid Due DateOnline PortalDeadline to indicate your intent to BidNov 16th 2023, 12:00 PM ESTYesPassedQuestions Due DateOnline PortalDeadline to submit QuestionsNov 2nd 2023, 1:00 PM EDTN/A Supporting Documentation:1-24-2-14-5 Bidding Documents.pdfDocumentationOct 19th 2023, 8:29 AM EDT - 1-24-2-14-5 Addendum No. 1.pdfAddendaNov 1st 2023, 1:10 PM EDT - 1-24-2-14-5 SBR Solicitation Only.pdfDocumentationOct 19th 2023, 8:27 AM EDT - Commodity Codes: UNSPSC 12 Chemicals including Bio Chemicals and Gas Materials: This segment includes inorganic and organic chemicals and compounds in solid, liquid or gaseous form used in an industrial or manufacturing process UNSPSC 12352316 Sodium hydroxide: A chemical compound known as NaOH UNSPSC 51101677 Sodium stibogluconate: This classification denotes an enzyme inhibitor and antiparasitic agent with the molecular formula C12H18O17Sb2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V083S0159D, chemically known as trinatrium bis(gluconato(3)-o2,o3,o4)hydroxooxido-oxy-bis-antimonat(v) but generally known as sodium stibogluconate, which bears US NIH Compound Identifier 16683012. European Medicines Agency schedules Sodium stibogluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04492MIG. World Health Organization schedules sodium stibogluconate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule Sodium stibogluconate under HS 29420000 and SITC 51699. As of Q4 2014, SODIUM STIBOGLUCONATE remains the US FDA Preferred Term for this commodity. Sodium stibogluconate bears US NLM identifiers UMLS ID C0030895 and NCI Concept Code C61083. SMILES: C([C@H]([C@@H]1[C@@H]([C@@H](O[SB](=O)(O1)O[SB]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.[NA+].[NA+]. UNSPSC 51111907 Sodium phenylbutyrate: This classification denotes a phenylbutyrate and antineoplastic agent with the molecular formula C10H11O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NT6K61736T, chemically known as benzenebutanoic acid, sodium salt but generally known as sodium phenylbutyrate, which bears US NIH Compound Identifier 15585. European Medicines Agency schedules Sodium phenylbutyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12586MIG. World Health Organization schedules sodium phenylbutyrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SODIUM PHENYLBUTYRATE remains the US FDA Preferred Term for this commodity. Sodium phenylbutyrate bears US NLM identifiers UMLS ID C0718066 and NCI Concept Code C1440. SMILES: C1=CC=C(C=C1)CCCC(=O)[O-].[NA+]. UNSPSC 51171629 Sodium sulfate: This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0YPR65R21J. European Medicines Agency schedules Sodium sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15325MIG. Sodium sulfate generally arises in the molecular formula NA2O4S. The term 'sodium sulfate' is a United States Homeopathic Pharmacopoeia Name designation. As of Q4 2014, SODIUM SULFATE remains the US FDA Preferred Term for this commodity. Sodium sulfate bears US NLM identifiers UMLS ID C0074769 and NCI Concept Code C47727. SMILES: S(=O)(=O)(O)O. UNSPSC 51171655 Sodium picosulfate: This classification denotes a laxative with the molecular formula C18H13NO8S2.2Na, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier LR57574HN8, chemically known as 4,4-(2-pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) disodium salt but more generally known as picosulfate sodium, which bears U.S. NIH Compound Identifier 68654. European Medicines Agency schedules Picosulfate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10569MIG. The term PICOSULFATE SODIUM is an International Non-Proprietary Name. World Health Organization schedules picosulfate sodium in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. UNSPSC 51172315 Sodium thiosulfate or thiosulfate or thiosulphate: This classification denotes a protective agent with the molecular formula 2Na.O3S2.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HX1032V43M, chemically known as thiosulfuric acid (h2s2o3), disodium salt but generally known as sodium thiosulfate, which bears US NIH Compound Identifier 24477. European Medicines Agency schedules Sodium thiosulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15332MIG. SMILES: [O-]S(=O)(=S)[O-].[NA+].[NA+]. UNSPSC 51172326 Sodium edetate: This classification denotes a chelating agent with the molecular formula C10H12N2O8.4Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MP1J8420LU, chemically known as tetrasodium ethylenediamine-n,n,n,n-tetraacetate but generally known as edetate sodium, which bears US NIH Compound Identifier 6144. European Medicines Agency schedules Edetate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37153. World Health Organization schedules edetate sodium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium edetate under HS 29224990 and SITC 51465. SMILES: [NA].[NA].[NA].[NA].OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O. UNSPSC 51172838 Sodium fluoride/sodium phosphate: This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR100. This VA Drug Class (OR100) classifies this compound as belonging to the group CARIOSTATICS, TOPICAL. UNSPSC 51182440 Sodium cellulose phosphate: This classification denotes a cation exchange resins and column chromatography, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier E6S1NJ4Y5Q. European Medicines Agency schedules Sodium cellulose phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15280MIG. Sodium cellulose phosphate generally arises in the molecular formula (C6H7O5)N.NA.O3P.H. The term 'sodium cellulose phosphate' is a United States Adopted Name designation. UNSPSC 51191566 Sodium acetate: This classification denotes an electrolyte replacement agent with the molecular formula C2H3O2.Na.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4550K0SC9B, chemically known as mercury acetate, hg (oac)2, compd. with 1,4-dihydroanthracene (1:1) but generally known as sodium acetate, which bears US NIH Compound Identifier 176. European Medicines Agency schedules Sodium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12576MIG. World Health Organization schedules sodium acetate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sodium acetate under HS 29152900 and SITC 51371. As of Q4 2014, SODIUM ACETATE remains the US FDA Preferred Term for this commodity. Sodium acetate bears US NLM identifiers UMLS ID C0142785 and NCI Concept Code C47720. SMILES: OC(=O)C.